The coordination module of the EU-funded projects RECOVER and EU-RESPONSE has launched its website https://covid19trials.eu/en. It centralises information for academics and industry on access to the three large Pan-European adaptive platform trials currently underway: DisCoVeRy, EU-SolidAct & REMAP-CAP.
The dedicated website describes the different bodies that aid in the coordination of the COVID-19 clinical trials and the roles they have been conferred. It describes how to access the Joint Access Advisory Mechanism (JAAM) which is the single access point for developers to propose new therapeutic solutions that can be evaluated in Phase II or Phase III trials.
Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.
Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.